Drugs of Bioengineered Protein Market - Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: D0FFCDC1A4F3EN
Market Monitor Global

Abstracts

Bioengineered proteins are synthesized using genetic engineering. They are also called as recombinant protein. Bioengineered protein drugs are used in treatment of human injury, treatment of cancers, hormonal disorders and chronic diseases such as diabetes, asthma, heart disease etc.

This report contains market size and forecasts of Drugs of Bioengineered Protein in Global, including the following market information:

Global Drugs of Bioengineered Protein Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Drugs of Bioengineered Protein market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drugs of Bioengineered Protein include GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Sanofi, Eli Lilly, Roche, Dr. Reddy's Laboratories and Abbott Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs of Bioengineered Protein companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs of Bioengineered Protein Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Drugs of Bioengineered Protein Market Segment Percentages, by Type, 2021 (%)

• Monoclonal Antibodies
• Therapeutic Proteins
• Vaccines

Global Drugs of Bioengineered Protein Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Drugs of Bioengineered Protein Market Segment Percentages, by Application, 2021 (%)

• Endocrinology
• Immunology
• Hematology
• Infectiology
• Neurology
• Oncology
• Genetic Disorder

Global Drugs of Bioengineered Protein Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Drugs of Bioengineered Protein Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drugs of Bioengineered Protein revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Drugs of Bioengineered Protein revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Novartis
• Sanofi
• Eli Lilly
• Roche
• Dr. Reddy's Laboratories
• Abbott Laboratories
• Amgen
• Bayer AG
• Biocon
• Fresenius kabi
• Panacea Biotec

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drugs of Bioengineered Protein Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drugs of Bioengineered Protein Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUGS OF BIOENGINEERED PROTEIN OVERALL MARKET SIZE

2.1 Global Drugs of Bioengineered Protein Market Size: 2021 VS 2028
2.2 Global Drugs of Bioengineered Protein Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Drugs of Bioengineered Protein Players in Global Market
3.2 Top Global Drugs of Bioengineered Protein Companies Ranked by Revenue
3.3 Global Drugs of Bioengineered Protein Revenue by Companies
3.4 Top 3 and Top 5 Drugs of Bioengineered Protein Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drugs of Bioengineered Protein Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs of Bioengineered Protein Players in Global Market
  3.6.1 List of Global Tier 1 Drugs of Bioengineered Protein Companies
  3.6.2 List of Global Tier 2 and Tier 3 Drugs of Bioengineered Protein Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Drugs of Bioengineered Protein Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibodies
  4.1.3 Therapeutic Proteins
  4.1.4 Vaccines
4.2 By Type - Global Drugs of Bioengineered Protein Revenue & Forecasts
  4.2.1 By Type - Global Drugs of Bioengineered Protein Revenue, 2017-2022
  4.2.2 By Type - Global Drugs of Bioengineered Protein Revenue, 2023-2028
  4.2.3 By Type - Global Drugs of Bioengineered Protein Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drugs of Bioengineered Protein Market Size, 2021 & 2028
  5.1.2 Endocrinology
  5.1.3 Immunology
  5.1.4 Hematology
  5.1.5 Infectiology
  5.1.6 Neurology
  5.1.7 Oncology
  5.1.8 Genetic Disorder
5.2 By Application - Global Drugs of Bioengineered Protein Revenue & Forecasts
  5.2.1 By Application - Global Drugs of Bioengineered Protein Revenue, 2017-2022
  5.2.2 By Application - Global Drugs of Bioengineered Protein Revenue, 2023-2028
  5.2.3 By Application - Global Drugs of Bioengineered Protein Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Drugs of Bioengineered Protein Market Size, 2021 & 2028
6.2 By Region - Global Drugs of Bioengineered Protein Revenue & Forecasts
  6.2.1 By Region - Global Drugs of Bioengineered Protein Revenue, 2017-2022
  6.2.2 By Region - Global Drugs of Bioengineered Protein Revenue, 2023-2028
  6.2.3 By Region - Global Drugs of Bioengineered Protein Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Drugs of Bioengineered Protein Revenue, 2017-2028
  6.3.2 US Drugs of Bioengineered Protein Market Size, 2017-2028
  6.3.3 Canada Drugs of Bioengineered Protein Market Size, 2017-2028
  6.3.4 Mexico Drugs of Bioengineered Protein Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Drugs of Bioengineered Protein Revenue, 2017-2028
  6.4.2 Germany Drugs of Bioengineered Protein Market Size, 2017-2028
  6.4.3 France Drugs of Bioengineered Protein Market Size, 2017-2028
  6.4.4 U.K. Drugs of Bioengineered Protein Market Size, 2017-2028
  6.4.5 Italy Drugs of Bioengineered Protein Market Size, 2017-2028
  6.4.6 Russia Drugs of Bioengineered Protein Market Size, 2017-2028
  6.4.7 Nordic Countries Drugs of Bioengineered Protein Market Size, 2017-2028
  6.4.8 Benelux Drugs of Bioengineered Protein Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Drugs of Bioengineered Protein Revenue, 2017-2028
  6.5.2 China Drugs of Bioengineered Protein Market Size, 2017-2028
  6.5.3 Japan Drugs of Bioengineered Protein Market Size, 2017-2028
  6.5.4 South Korea Drugs of Bioengineered Protein Market Size, 2017-2028
  6.5.5 Southeast Asia Drugs of Bioengineered Protein Market Size, 2017-2028
  6.5.6 India Drugs of Bioengineered Protein Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Drugs of Bioengineered Protein Revenue, 2017-2028
  6.6.2 Brazil Drugs of Bioengineered Protein Market Size, 2017-2028
  6.6.3 Argentina Drugs of Bioengineered Protein Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Drugs of Bioengineered Protein Revenue, 2017-2028
  6.7.2 Turkey Drugs of Bioengineered Protein Market Size, 2017-2028
  6.7.3 Israel Drugs of Bioengineered Protein Market Size, 2017-2028
  6.7.4 Saudi Arabia Drugs of Bioengineered Protein Market Size, 2017-2028
  6.7.5 UAE Drugs of Bioengineered Protein Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Drugs of Bioengineered Protein Major Product Offerings
  7.1.4 GlaxoSmithKline Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Drugs of Bioengineered Protein Major Product Offerings
  7.2.4 Johnson & Johnson Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Drugs of Bioengineered Protein Major Product Offerings
  7.3.4 Merck Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.3.5 Merck Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Drugs of Bioengineered Protein Major Product Offerings
  7.4.4 Novartis Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Drugs of Bioengineered Protein Major Product Offerings
  7.5.4 Sanofi Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 Eli Lilly
  7.6.1 Eli Lilly Corporate Summary
  7.6.2 Eli Lilly Business Overview
  7.6.3 Eli Lilly Drugs of Bioengineered Protein Major Product Offerings
  7.6.4 Eli Lilly Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.6.5 Eli Lilly Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Drugs of Bioengineered Protein Major Product Offerings
  7.7.4 Roche Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 Dr. Reddy's Laboratories
  7.8.1 Dr. Reddy's Laboratories Corporate Summary
  7.8.2 Dr. Reddy's Laboratories Business Overview
  7.8.3 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Major Product Offerings
  7.8.4 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.8.5 Dr. Reddy's Laboratories Key News
7.9 Abbott Laboratories
  7.9.1 Abbott Laboratories Corporate Summary
  7.9.2 Abbott Laboratories Business Overview
  7.9.3 Abbott Laboratories Drugs of Bioengineered Protein Major Product Offerings
  7.9.4 Abbott Laboratories Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.9.5 Abbott Laboratories Key News
7.10 Amgen
  7.10.1 Amgen Corporate Summary
  7.10.2 Amgen Business Overview
  7.10.3 Amgen Drugs of Bioengineered Protein Major Product Offerings
  7.10.4 Amgen Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.10.5 Amgen Key News
7.11 Bayer AG
  7.11.1 Bayer AG Corporate Summary
  7.11.2 Bayer AG Business Overview
  7.11.3 Bayer AG Drugs of Bioengineered Protein Major Product Offerings
  7.11.4 Bayer AG Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.11.5 Bayer AG Key News
7.12 Biocon
  7.12.1 Biocon Corporate Summary
  7.12.2 Biocon Business Overview
  7.12.3 Biocon Drugs of Bioengineered Protein Major Product Offerings
  7.12.4 Biocon Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.12.5 Biocon Key News
7.13 Fresenius kabi
  7.13.1 Fresenius kabi Corporate Summary
  7.13.2 Fresenius kabi Business Overview
  7.13.3 Fresenius kabi Drugs of Bioengineered Protein Major Product Offerings
  7.13.4 Fresenius kabi Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.13.5 Fresenius kabi Key News
7.14 Panacea Biotec
  7.14.1 Panacea Biotec Corporate Summary
  7.14.2 Panacea Biotec Business Overview
  7.14.3 Panacea Biotec Drugs of Bioengineered Protein Major Product Offerings
  7.14.4 Panacea Biotec Drugs of Bioengineered Protein Revenue in Global Market (2017-2022)
  7.14.5 Panacea Biotec Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Drugs of Bioengineered Protein Market Opportunities & Trends in Global Market
Table 2. Drugs of Bioengineered Protein Market Drivers in Global Market
Table 3. Drugs of Bioengineered Protein Market Restraints in Global Market
Table 4. Key Players of Drugs of Bioengineered Protein in Global Market
Table 5. Top Drugs of Bioengineered Protein Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drugs of Bioengineered Protein Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drugs of Bioengineered Protein Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drugs of Bioengineered Protein Product Type
Table 9. List of Global Tier 1 Drugs of Bioengineered Protein Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs of Bioengineered Protein Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Drugs of Bioengineered Protein Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drugs of Bioengineered Protein Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drugs of Bioengineered Protein Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Drugs of Bioengineered Protein Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drugs of Bioengineered Protein Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drugs of Bioengineered Protein Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Drugs of Bioengineered Protein Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drugs of Bioengineered Protein Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drugs of Bioengineered Protein Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drugs of Bioengineered Protein Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drugs of Bioengineered Protein Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drugs of Bioengineered Protein Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drugs of Bioengineered Protein Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Drugs of Bioengineered Protein Product Offerings
Table 32. GlaxoSmithKline Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Drugs of Bioengineered Protein Product Offerings
Table 35. Johnson & Johnson Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Drugs of Bioengineered Protein Product Offerings
Table 38. Merck Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Drugs of Bioengineered Protein Product Offerings
Table 41. Novartis Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Drugs of Bioengineered Protein Product Offerings
Table 44. Sanofi Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Drugs of Bioengineered Protein Product Offerings
Table 47. Eli Lilly Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Drugs of Bioengineered Protein Product Offerings
Table 50. Roche Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 51. Dr. Reddy's Laboratories Corporate Summary
Table 52. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product Offerings
Table 53. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 54. Abbott Laboratories Corporate Summary
Table 55. Abbott Laboratories Drugs of Bioengineered Protein Product Offerings
Table 56. Abbott Laboratories Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 57. Amgen Corporate Summary
Table 58. Amgen Drugs of Bioengineered Protein Product Offerings
Table 59. Amgen Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 60. Bayer AG Corporate Summary
Table 61. Bayer AG Drugs of Bioengineered Protein Product Offerings
Table 62. Bayer AG Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 63. Biocon Corporate Summary
Table 64. Biocon Drugs of Bioengineered Protein Product Offerings
Table 65. Biocon Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 66. Fresenius kabi Corporate Summary
Table 67. Fresenius kabi Drugs of Bioengineered Protein Product Offerings
Table 68. Fresenius kabi Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)
Table 69. Panacea Biotec Corporate Summary
Table 70. Panacea Biotec Drugs of Bioengineered Protein Product Offerings
Table 71. Panacea Biotec Drugs of Bioengineered Protein Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Drugs of Bioengineered Protein Segment by Type in 2021
Figure 2. Drugs of Bioengineered Protein Segment by Application in 2021
Figure 3. Global Drugs of Bioengineered Protein Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drugs of Bioengineered Protein Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drugs of Bioengineered Protein Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs of Bioengineered Protein Revenue in 2021
Figure 8. By Type - Global Drugs of Bioengineered Protein Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drugs of Bioengineered Protein Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drugs of Bioengineered Protein Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drugs of Bioengineered Protein Revenue Market Share, 2017-2028
Figure 12. US Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drugs of Bioengineered Protein Revenue Market Share, 2017-2028
Figure 16. Germany Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 17. France Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drugs of Bioengineered Protein Revenue Market Share, 2017-2028
Figure 24. China Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 28. India Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drugs of Bioengineered Protein Revenue Market Share, 2017-2028
Figure 30. Brazil Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drugs of Bioengineered Protein Revenue Market Share, 2017-2028
Figure 33. Turkey Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drugs of Bioengineered Protein Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbott Laboratories Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amgen Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bayer AG Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Biocon Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Fresenius kabi Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Panacea Biotec Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2017-2022)